Laman Utama45E • FRA
add
Natera Inc
Tutup sebelumnya
€173.00
Julat hari
€168.00 - €168.00
Julat tahun
€164.00 - €216.00
Permodalan pasaran
27.85B USD
Bilangan Purata
9.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 665.50J | 39.79% |
Perbelanjaan pengendalian | 468.21J | 28.50% |
Pendapatan bersih | 47.26J | 187.89% |
Margin untung bersih | 7.10 | 162.89% |
Pendapatan bagi setiap syer | 0.36 | 187.80% |
EBITDA | -13.69J | 77.35% |
Kadar cukai berkesan | 454.63% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.08B | 11.14% |
Jumlah aset | 2.40B | 44.41% |
Jumlah liabiliti | 685.93J | 47.41% |
Jumlah ekuiti | 1.71B | — |
Syer tertunggak | 141.73J | — |
Harga kepada buku | 14.11 | — |
Pulangan pada aset | -2.70% | — |
Pulangan pada modal | -3.37% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 47.26J | 187.89% |
Tunai daripada operasi | 73.89J | 39.71% |
Tunai daripada pelaburan | -71.59J | -543.93% |
Tunai daripada pembiayaan | 32.41J | 195.30% |
Perubahan bersih dalam tunai | 34.70J | -34.21% |
Aliran tunai bebas | 16.99J | -69.31% |
Perihal
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Diasaskan
1 Jan 2004
Ibu pejabat
Tapak web
Pekerja
6,138